Press Releases Novo Nordisk A/S Mexican S.E.

Equities

NVO N

US6701002056

End-of-day quote Mexican S.E. Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
2,578 ^MXN	+2.39%		-2.01%	+46.69%

10:36am	Eli Lilly, Novo Holdings Participate in Myricx Bio's $114 Million Financing Round	MT
07-05	Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Nordisk A/S - share repurchase programme	02:19pm	GL
Novo Holdings invests in MATR Foods expansion within plant-based fungi food	07-02	AQ
Novo Nordisk A/S - share repurchase programme	07-01	GL
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss	06-26	GL
New US fill finish facility receives $4.1 billion investment	06-26	AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery	06-26	AQ
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	06-24	GL
Novo Nordisk A/S - share repurchase programme	06-24	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	06-18	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	06-18	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	06-17	AQ
Novo Nordisk A/S - share repurchase programme	06-17	GL
Haemophilia drug could reduce treated bleeding episodes	06-13	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	06-11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	06-11	AQ
Novo Nordisk A/S - share repurchase programme	06-10	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Novo Nordisk A/S - share repurchase programme	06-03	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Novo Nordisk A/S - share repurchase programme	05-27	GL